MXPA03009548A - Arilsulfonamidas como agentes antivirales. - Google Patents

Arilsulfonamidas como agentes antivirales.

Info

Publication number
MXPA03009548A
MXPA03009548A MXPA03009548A MXPA03009548A MXPA03009548A MX PA03009548 A MXPA03009548 A MX PA03009548A MX PA03009548 A MXPA03009548 A MX PA03009548A MX PA03009548 A MXPA03009548 A MX PA03009548A MX PA03009548 A MXPA03009548 A MX PA03009548A
Authority
MX
Mexico
Prior art keywords
antiviral agents
arylsulfonamides
arylsulphonamides
substituents
novel
Prior art date
Application number
MXPA03009548A
Other languages
English (en)
Spanish (es)
Inventor
Raddatz Siegfried
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10148598A external-priority patent/DE10148598A1/de
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of MXPA03009548A publication Critical patent/MXPA03009548A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
MXPA03009548A 2001-04-19 2002-04-08 Arilsulfonamidas como agentes antivirales. MXPA03009548A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10119137 2001-04-19
DE10148598A DE10148598A1 (de) 2001-04-19 2001-10-02 Neue Arylsulfonamide als antivirale Mittel
PCT/EP2002/003858 WO2002085869A1 (de) 2001-04-19 2002-04-08 Arylsulfonamide als antivirale mittel

Publications (1)

Publication Number Publication Date
MXPA03009548A true MXPA03009548A (es) 2004-05-24

Family

ID=26009118

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03009548A MXPA03009548A (es) 2001-04-19 2002-04-08 Arilsulfonamidas como agentes antivirales.

Country Status (20)

Country Link
US (1) US7115612B2 (enExample)
EP (1) EP1383749B1 (enExample)
JP (1) JP4480941B2 (enExample)
CN (1) CN1516695A (enExample)
AT (1) ATE308529T1 (enExample)
BG (1) BG108272A (enExample)
BR (1) BR0209054A (enExample)
CA (1) CA2444123C (enExample)
DE (1) DE50204780D1 (enExample)
EE (1) EE200300515A (enExample)
ES (1) ES2252455T3 (enExample)
HU (1) HUP0303813A3 (enExample)
IL (1) IL158324A0 (enExample)
MX (1) MXPA03009548A (enExample)
NO (1) NO20034667L (enExample)
PL (1) PL363990A1 (enExample)
RU (1) RU2003133750A (enExample)
SK (1) SK12662003A3 (enExample)
UY (1) UY27263A1 (enExample)
WO (1) WO2002085869A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20050168A2 (en) * 2002-08-23 2005-10-31 Rigel Pharmaceuticals Pyridyl substituted heterocycles useful for treating or preventing hcv infection
DE10319612A1 (de) 2003-05-02 2004-11-18 Bayer Healthcare Ag Substituierte Dihydrochinazoline
EP4101846B1 (en) 2003-04-11 2023-08-02 PTC Therapeutics, Inc. 1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease
DE102006009928A1 (de) * 2006-03-03 2007-09-06 Aicuris Gmbh & Co. Kg Substituierte Arylsulfonamide
EP2387995A1 (en) 2006-03-30 2011-11-23 PTC Therapeutics, Inc. Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith
US20080255203A1 (en) * 2007-04-12 2008-10-16 Abbott Laboratories Heterocyclic compounds and their methods of use
CA2692379A1 (en) * 2007-07-02 2009-01-08 Boehringer Ingelheim International Gmbh Antiproliferative compounds based on 5-membered heterocycles
EP2177521A1 (en) * 2008-10-14 2010-04-21 Almirall, S.A. New 2-Amidothiadiazole Derivatives
EP2202232A1 (en) * 2008-12-26 2010-06-30 Laboratorios Almirall, S.A. 1,2,4-oxadiazole derivatives and their therapeutic use
CN103119036B (zh) * 2010-06-28 2018-05-08 拜耳知识产权有限责任公司 作为杀虫剂的杂环化合物
JP2013531687A (ja) 2010-07-16 2013-08-08 パーデュー、ファーマ、リミテッド、パートナーシップ ナトリウムチャネル遮断剤としてのピリジン化合物
WO2013136170A1 (en) 2012-03-16 2013-09-19 Purdue Pharma L.P. Substituted pyridines as sodium channel blockers
US9284310B2 (en) 2012-11-03 2016-03-15 Boehringer Ingelheim International Gmbh Inhibitors of cytomegalovirus
EP2914592B1 (en) 2012-11-03 2017-10-11 Boehringer Ingelheim International GmbH Inhibitors of cytomegalovirus
EP2935257B1 (en) 2012-12-20 2018-02-07 Purdue Pharma LP Cyclic sulfonamides as sodium channel blockers
WO2015134711A1 (en) 2014-03-06 2015-09-11 Ptc Therapeutics, Inc. Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid
US10730866B2 (en) 2014-04-07 2020-08-04 Purdue Pharma L.P. Indole derivatives and use thereof
EP3256461B1 (en) * 2015-02-13 2023-09-13 Azienda Ospedaliera Universitaria Senese Urea and sulfonamide derivatives as human helicase ddx3 inhibitors useful in the treatment of viral diseases
TW201729807A (zh) 2015-10-30 2017-09-01 Ｐｔｃ治療公司 用於治療癲癇的方法
EP3601274A1 (en) * 2017-03-31 2020-02-05 Perenna Pharmaceuticals, Inc. Compounds useful as inhibitors of alcat 1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19802437A1 (de) 1998-01-23 1999-07-29 Bayer Ag Verwendung von substituierten Sulfonamiden als anitvirale Mittel und neue Stoffe
PL351374A1 (en) * 1999-04-19 2003-04-07 Shionogi & Co Sulfonamide derivatives having oxadiazole rings

Also Published As

Publication number Publication date
UY27263A1 (es) 2002-11-29
EP1383749B1 (de) 2005-11-02
DE50204780D1 (de) 2005-12-08
HUP0303813A3 (en) 2005-05-30
WO2002085869A1 (de) 2002-10-31
JP2004531536A (ja) 2004-10-14
JP4480941B2 (ja) 2010-06-16
RU2003133750A (ru) 2005-05-10
NO20034667D0 (no) 2003-10-17
ES2252455T3 (es) 2006-05-16
EP1383749A1 (de) 2004-01-28
CA2444123A1 (en) 2002-10-31
NO20034667L (no) 2003-12-12
US7115612B2 (en) 2006-10-03
CN1516695A (zh) 2004-07-28
HUP0303813A2 (hu) 2004-03-29
BR0209054A (pt) 2004-04-20
BG108272A (bg) 2004-10-29
SK12662003A3 (sk) 2004-04-06
US20040176374A1 (en) 2004-09-09
ATE308529T1 (de) 2005-11-15
CA2444123C (en) 2010-09-21
PL363990A1 (en) 2004-11-29
EE200300515A (et) 2004-02-16
IL158324A0 (en) 2004-05-12

Similar Documents

Publication Publication Date Title
DE602004008895D1 (en) Dpp-iv-hemmer
MXPA04002067A (es) Nuevas dihidropteridinonas, procedimientos para su preparacion y su uso como medicamento.
YU29503A (sh) Novi antiholinergici koji se mogu primeniti kao lekovi, kao i postupak za njihovo dobijanje
AP1614A (en) New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents.
MXPA02009567A (es) Benzoilpirzoles y su uso como herbicidas.
MXPA05011707A (es) Dihidroquinazolinas sustituidas con propiedades antivirales.
MXPA02011370A (es) Iminoazinas substituidas.
AU2002319814A1 (en) Substituted 1h-dihydropyrazoles, their preparation and use
EA200500017A1 (ru) Новые соединения
BG106013A (en) New compounds and compositions as protease inhibitors
MX2007000505A (es) Derivados de oxindol sustituidos y medicamentos que contienen los mismos.
PL363990A1 (en) Arylsulfonamides as antiviral agents
MXPA03008755A (es) Derivados de 2-amino-propanol.
MXPA05011962A (es) Oxiarenos substituidos.
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
MXPA03008811A (es) Procedimiento para la preparacion de 4,6-diaminopirimido (5,4-d) pirimidinas.
MXPA04002282A (es) Nuevos compuestos y preparaciones como inhibidores de la catepsina.
BG104617A (en) Novel naphthyl-substituted and anilide-substituted sulfonamides
MXPA03010120A (es) Arilcetonas substituidas.
MXPA02001406A (es) Heterociclilos-2h-cromenos substituidos.
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
WO2003014094A3 (de) Heterocyclylarylsulfonamide
DE50311388D1 (de) Nicht-peptidische brs-3-agonisten
MXPA03012073A (es) Amidoderivados heterociclicos.
MXPA04000623A (es) Derivados de tetrahidropiridazina y su uso como pesticidas.